Protein Official symbol | ADA |
Aliases | ADA ADA1 |
Chromosomal Location | 20 |
Length | 363 |
Uniprot ID | P00813 |
EC number | 3.5.4.4 |
Protein family Information(Pfam) | PF00962; |
PDB id | 1M7M;3IAR; |
InterPro ID | IPR006650;IPR001365;IPR028893;IPR006330;IPR032466; |
dbSNP | rs73598374 rs121908725 rs121908724 rs121908730 rs121908736 rs11555566 rs121908726 rs267606634 rs121908714 rs121908714 rs121908717 rs267606635 rs121908739 rs121908731 rs121908732 rs61732239 rs121908737 rs121908733 rs121908728 rs121908735 rs121908722 rs121908719 rs121908727 rs121908734 rs121908740 rs121908716 rs114025668 rs121908723 rs121908729 rs121908738 rs121908721 rs121908718 rs199422327 rs121908715 |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
ADA | PNP | 0.996 |
ADA | ADK | 0.995 |
PNP | ADK | 0.989 |
NT5C3A | NT5C | 0.979 |
ADA | NT5E | 0.971 |
NT5C2 | DCK | 0.968 |
ADK | NT5E | 0.968 |
PNP | DCK | 0.963 |
ADA | DCK | 0.962 |
CECR1 | PNP | 0.957 |
CECR1 | ADK | 0.956 |
NT5C2 | NT5C1A | 0.956 |
NT5C3A | NT5C2 | 0.952 |
CECR1 | ADA | 0.945 |
PNP | NT5C2 | 0.945 |
NT5C3B | NT5C1B | 0.945 |
NT5C | NT5C1A | 0.944 |
NT5C3A | NT5C1A | 0.944 |
NT5C3B | NT5C1A | 0.944 |
NT5C3A | DCK | 0.943 |
DCK | NT5C | 0.94 |
PNP | NT5E | 0.94 |
NT5M | DCK | 0.938 |
NT5C2 | ADK | 0.937 |
ADA | NT5C2 | 0.935 |
NT5C1B | NT5C | 0.934 |
NT5M | NT5C1A | 0.933 |
DCK | NT5C1A | 0.932 |
NT5C2 | NT5C | 0.932 |
NT5C1B | NT5C2 | 0.931 |
ADA | ADAR | 0.929 |
NT5M | NT5C1B | 0.928 |
NT5C1B | DCK | 0.925 |
NT5M | NT5C2 | 0.923 |
ADK | NT5C1A | 0.923 |
PNP | NT5C1A | 0.923 |
NT5C3A | NT5C1B | 0.921 |
ADA | NT5C1A | 0.921 |
DCK | NT5E | 0.92 |
NT5C3B | PNP | 0.92 |
NT5C3B | NT5C2 | 0.918 |
NT5C3A | PNP | 0.917 |
NT5C3B | ADK | 0.917 |
NT5C3B | DCK | 0.915 |
NT5C3B | NT5M | 0.915 |
ADA | NT5C | 0.914 |
PNP | NT5C | 0.913 |
NT5C1B | ADK | 0.913 |
NT5C3A | ADA | 0.912 |
NT5M | NT5E | 0.911 |
NT5M | ADK | 0.91 |
NT5M | ADA | 0.908 |
NT5C3B | ADA | 0.907 |
NT5C3A | ADK | 0.905 |
ADA | NT5C1B | 0.904 |
RDH14 | ADA | 0.903 |
NT5M | PNP | 0.903 |
ENSG00000250741 | PNP | 0.902 |
PNP | NT5C1B | 0.902 |
ADK | NT5C | 0.902 |
ENSG00000250741 | ADA | 0.9 |
ENSG00000250741 | ADK | 0.9 |
CECR1 | DCK | 0.9 |
NT5C3A | NT5M | 0.9 |
ENSG00000250741 | DCK | 0.9 |
NT5C3B | NT5C | 0.9 |
# | 100 (ADA) | 103 (ADAR) | 132 (ADK) | 1633 (DCK) | 4860 (PNP) | 4907 (NT5E) | 22978 (NT5C2) | 30833 (NT5C) | 51251 (NT5C3A) | 51816 (CECR1) | 56953 (NT5M) | 57665 (RDH14) | 84618 (NT5C1A) | 93034 (NT5C1B) | 115024 (NT5C3B) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100 (ADA) | 1.00 | 0.71 | 0.26 | 0.36 | 0.38 | 0.27 | 0.51 | 0.28 | 0.40 | 0.80 | 0.22 | 0.18 | 0.57 | 0.27 | 0.57 |
103 (ADAR) | 0.71 | 1.00 | 0.53 | 0.33 | 0.42 | 0.24 | 0.45 | 0.33 | 0.25 | 0.61 | 0.19 | 0.15 | 0.49 | 0.24 | 0.49 |
132 (ADK) | 0.26 | 0.53 | 1.00 | 0.56 | 0.39 | 0.12 | 0.47 | 0.26 | 0.33 | 0.22 | 0.12 | 0.12 | 0.25 | 0.12 | 0.25 |
1633 (DCK) | 0.36 | 0.33 | 0.56 | 1.00 | 0.45 | 0.13 | 0.56 | 0.19 | 0.33 | 0.42 | 0.13 | 0.13 | 0.33 | 0.13 | 0.33 |
4860 (PNP) | 0.38 | 0.42 | 0.39 | 0.45 | 1.00 | 0.15 | 0.37 | 0.35 | 0.30 | 0.33 | 0.13 | 0.15 | 0.37 | 0.15 | 0.37 |
4907 (NT5E) | 0.27 | 0.24 | 0.12 | 0.13 | 0.15 | 1.00 | 1.00 | 1.00 | 1.00 | 0.27 | 1.00 | 0.11 | 1.00 | 1.00 | 1.00 |
22978 (NT5C2) | 0.51 | 0.45 | 0.47 | 0.56 | 0.37 | 1.00 | 1.00 | 0.61 | 0.64 | 0.47 | 0.63 | 0.13 | 0.83 | 1.00 | 0.83 |
30833 (NT5C) | 0.28 | 0.33 | 0.26 | 0.19 | 0.35 | 1.00 | 0.61 | 1.00 | 0.57 | 0.23 | 0.82 | 0.13 | 0.70 | 1.00 | 0.70 |
51251 (NT5C3A) | 0.40 | 0.25 | 0.33 | 0.33 | 0.30 | 1.00 | 0.64 | 0.57 | 1.00 | 0.32 | 0.63 | 0.16 | 0.57 | 1.00 | 0.57 |
51816 (CECR1) | 0.80 | 0.61 | 0.22 | 0.42 | 0.33 | 0.27 | 0.47 | 0.23 | 0.32 | 1.00 | 0.16 | 0.18 | 0.51 | 0.27 | 0.51 |
56953 (NT5M) | 0.22 | 0.19 | 0.12 | 0.13 | 0.13 | 1.00 | 0.63 | 0.82 | 0.63 | 0.16 | 1.00 | 0.13 | 0.75 | 1.00 | 0.75 |
57665 (RDH14) | 0.18 | 0.15 | 0.12 | 0.13 | 0.15 | 0.11 | 0.13 | 0.13 | 0.16 | 0.18 | 0.13 | 1.00 | 0.13 | 0.11 | 0.13 |
84618 (NT5C1A) | 0.57 | 0.49 | 0.25 | 0.33 | 0.37 | 1.00 | 0.83 | 0.70 | 0.57 | 0.51 | 0.75 | 0.13 | 1.00 | 1.00 | 1.00 |
93034 (NT5C1B) | 0.27 | 0.24 | 0.12 | 0.13 | 0.15 | 1.00 | 1.00 | 1.00 | 1.00 | 0.27 | 1.00 | 0.11 | 1.00 | 1.00 | 1.00 |
115024 (NT5C3B) | 0.57 | 0.49 | 0.25 | 0.33 | 0.37 | 1.00 | 0.83 | 0.70 | 0.57 | 0.51 | 0.75 | 0.13 | 1.00 | 1.00 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADA | Bird | Kidney | - | 4000 m | Native | downregulated | -2.05 | Sequencing | Central Asia | L. dichrous (Bird) | 1 | L. dichrous vs. Po. Palustris | 31127049 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT027685 | hsa-miR-98-5p | Homo sapiens | ADA | 100 | Homo sapiens | Microarray | Functional MTI (Weak) | 19088304 |
MIRT041891 | hsa-miR-484 | Homo sapiens | ADA | 100 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT438367 | hsa-miR-140-5p | Homo sapiens | ADA | 100 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 24530397 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
100 | GO:0001890 | placenta development | GOTERM_BP_DIRECT |
100 | GO:0032261 | purine nucleotide salvage | GOTERM_BP_DIRECT |
100 | GO:0005886 | plasma membrane | GOTERM_CC_DIRECT |
100 | GO:0001889 | liver development | GOTERM_BP_DIRECT |
100 | GO:0001829 | trophectodermal cell differentiation | GOTERM_BP_DIRECT |
100 | GO:0002906 | negative regulation of mature B cell apoptotic process | GOTERM_BP_DIRECT |
100 | GO:0042542 | response to hydrogen peroxide | GOTERM_BP_DIRECT |
100 | GO:0005829 | cytosol | GOTERM_CC_DIRECT |
100 | GO:0002686 | negative regulation of leukocyte migration | GOTERM_BP_DIRECT |
100 | GO:0010460 | positive regulation of heart rate | GOTERM_BP_DIRECT |
100 | GO:0042110 | T cell activation | GOTERM_BP_DIRECT |
100 | GO:0046103 | inosine biosynthetic process | GOTERM_BP_DIRECT |
100 | GO:0050728 | negative regulation of inflammatory response | GOTERM_BP_DIRECT |
100 | GO:0070256 | negative regulation of mucus secretion | GOTERM_BP_DIRECT |
100 | GO:0006154 | adenosine catabolic process | GOTERM_BP_DIRECT |
100 | GO:0046638 | positive regulation of alpha-beta T cell differentiation | GOTERM_BP_DIRECT |
100 | GO:0060407 | negative regulation of penile erection | GOTERM_BP_DIRECT |
100 | GO:0005615 | extracellular space | GOTERM_CC_DIRECT |
100 | GO:0009897 | external side of plasma membrane | GOTERM_CC_DIRECT |
100 | GO:0001666 | response to hypoxia | GOTERM_BP_DIRECT |
100 | GO:0042323 | negative regulation of circadian sleep/wake cycle | GOTERM_BP_DIRECT |
100 | GO:0043101 | purine-containing compound salvage | GOTERM_BP_DIRECT |
100 | GO:0050862 | positive regulation of T cell receptor signaling pathway | GOTERM_BP_DIRECT |
100 | GO:0004000 | acyl-CoA dehydrogenase activity | GOTERM_MF_DIRECT |
100 | GO:0043025 | neuronal cell body | GOTERM_CC_DIRECT |
100 | GO:0007568 | aging | GOTERM_BP_DIRECT |
100 | GO:0042493 | response to drug | GOTERM_BP_DIRECT |
100 | GO:0046101 | hypoxanthine biosynthetic process | GOTERM_BP_DIRECT |
100 | GO:0016020 | membrane | GOTERM_CC_DIRECT |
100 | GO:0030054 | cell junction | GOTERM_CC_DIRECT |
100 | GO:0043103 | hypoxanthine salvage | GOTERM_BP_DIRECT |
100 | GO:0048566 | embryonic digestive tract development | GOTERM_BP_DIRECT |
100 | GO:0070244 | negative regulation of thymocyte apoptotic process | GOTERM_BP_DIRECT |
100 | GO:0033089 | positive regulation of T cell differentiation in thymus | GOTERM_BP_DIRECT |
100 | GO:0043278 | response to morphine | GOTERM_BP_DIRECT |
100 | GO:0045987 | positive regulation of smooth muscle contraction | GOTERM_BP_DIRECT |
100 | GO:0048541 | Peyer's patch development | GOTERM_BP_DIRECT |
100 | GO:0001883 | complement component C1q binding | GOTERM_MF_DIRECT |
100 | GO:0005764 | lysosome | GOTERM_CC_DIRECT |
100 | GO:0002636 | positive regulation of germinal center formation | GOTERM_BP_DIRECT |
100 | GO:0033197 | response to vitamin E | GOTERM_BP_DIRECT |
100 | GO:0019239 | kinase regulator activity | GOTERM_MF_DIRECT |
100 | GO:0009986 | cell surface | GOTERM_CC_DIRECT |
100 | GO:0032839 | dendrite cytoplasm | GOTERM_CC_DIRECT |
100 | GO:0030890 | positive regulation of B cell proliferation | GOTERM_BP_DIRECT |
100 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin | GOTERM_BP_DIRECT |
100 | GO:0046061 | dATP catabolic process | GOTERM_BP_DIRECT |
100 | GO:0048286 | lung alveolus development | GOTERM_BP_DIRECT |
100 | GO:0060169 | negative regulation of adenosine receptor signaling pathway | GOTERM_BP_DIRECT |
100 | GO:0005737 | cytoplasm | GOTERM_CC_DIRECT |
100 | GO:0002314 | germinal center B cell differentiation | GOTERM_BP_DIRECT |
100 | GO:0006157 | deoxyadenosine catabolic process | GOTERM_BP_DIRECT |
100 | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | GOTERM_BP_DIRECT |
100 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
100 | GO:0008270 | zinc ion binding | GOTERM_MF_DIRECT |
100 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen | GOTERM_CC_DIRECT |
100 | GO:0001821 | histamine secretion | GOTERM_BP_DIRECT |
100 | GO:0046111 | xanthine biosynthetic process | GOTERM_BP_DIRECT |
100 | GO:0050850 | positive regulation of calcium-mediated signaling | GOTERM_BP_DIRECT |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
ADA | 100 | Lung Neoplasms | C0024121 | Neoplastic Process | 0.3 | 0.494 | 0.793 | group |
ADA | 100 | Malignant neoplasm of lung | C0242379 | Neoplastic Process | 0.3 | 0.494 | 0.793 | disease |
ADA | 100 | Spinal Cord Diseases | C0037928 | Disease or Syndrome | 0.3 | 0.494 | 0.793 | group |
ADA | 100 | Liver Cirrhosis, Experimental | C0023893 | Experimental Model of Disease | 0.3 | 0.494 | 0.793 | disease |
ADA | 100 | Reactive Hyperemia | C0178824 | Pathologic Function | 0.3 | 0.494 | 0.793 | phenotype |
ADA | 100 | Venous Engorgement | C0042484 | Pathologic Function | 0.3 | 0.494 | 0.793 | phenotype |
ADA | 100 | Autistic Disorder | C0004352 | Mental or Behavioral Dysfunction | 0.34 | 0.494 | 0.793 | group |
ADA | 100 | Active Hyperemia | C0333233 | Pathologic Function | 0.3 | 0.494 | 0.793 | phenotype |
ADA | 100 | Hyperemia | C0020452 | Disease or Syndrome | 0.31 | 0.494 | 0.793 | disease |
ADA | 100 | Severe combined immunodeficiency due to adenosine deaminase deficiency | C0392607 | Disease or Syndrome | 0.7 | 0.494 | 0.793 | disease |
ADA | 100 | Partial adenosine deaminase deficiency | C1863239 | Disease or Syndrome | 0.63 | 0.494 | 0.793 | disease |
ADA | 100 | Omenn Syndrome | C2700553 | Disease or Syndrome | 0.31 | 0.494 | 0.793 | disease |
ADA | 100 | Adenosine deaminase deficiency | C0268124 | Disease or Syndrome | 0.6 | 0.494 | 0.793 | disease |
ADA | 100 | Pancreatic Ductal Adenocarcinoma | C1335302 | Neoplastic Process | 0.3 | 0.494 | 0.793 | disease |
ADA | 100 | SCID Due to ADA Deficiency, Early-Onset | C1863236 | Disease or Syndrome | 0.4 | 0.494 | 0.793 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|---|---|---|---|---|
ADA | 100 | 2,3-DIDEOXYADENOSINE | CHEMBL23094 | CHEMBL23094 | None |
ADA | 100 | 6-METHYLMERCAPTOPURINE RIBOSIDE | None | None | None |
ADA | 100 | AMITRIPTYLINE | AMITRIPTYLINE | CHEMBL629 | None |
ADA | 100 | ANTIMALARIALS | CHEMBL1255648 | CHEMBL1255648 | None |
ADA | 100 | CLADRIBINE | CLADRIBINE | CHEMBL1619 | inhibitor |
ADA | 100 | CHELATORS | None | None | None |
ADA | 100 | COBALT | None | None | None |
ADA | 100 | DIFFERENTIATING AGENTS | None | None | None |
ADA | 100 | DIPYRIDAMOLE | DIPYRIDAMOLE | CHEMBL932 | None |
ADA | 100 | DIPYRIDAMOLE | DIPYRIDAMOLE | CHEMBL932 | inhibitor |
ADA | 100 | DIPYRIDAMOLE | DIPYRIDAMOLE | CHEMBL932 | None |
ADA | 100 | EHNA | EHNA | CHEMBL50378 | inhibitor |
ADA | 100 | FLUDARABINE | FLUDARABINE | CHEMBL1568 | inhibitor |
ADA | 100 | GARLIC | GARLIC | CHEMBL2108463 | None |
ADA | 100 | H2O2 | HYDROGEN PEROXIDE | CHEMBL71595 | None |
ADA | 100 | HYDROCORTISONE | HYDROCORTISONE | CHEMBL389621 | None |
ADA | 100 | L-DOPA | LEVODOPA | CHEMBL1009 | None |
ADA | 100 | METHOTREXATE | METHOTREXATE | CHEMBL34259 | None |
ADA | 100 | NG-MONOMETHYL-L-ARGININE | TARGININE | CHEMBL256147 | None |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | inhibitor |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | None |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | inhibitor |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | inhibitor |
ADA | 100 | PENTOSTATIN | PENTOSTATIN | CHEMBL1580 | None |
ADA | 100 | PROTHYMOSIN ALPHA | None | None | None |
ADA | 100 | RECOMBINANT INTERLEUKIN | None | None | None |
ADA | 100 | SELENIUM | None | None | None |